Elevation Oncology Inc. (ELEV)

Market is closed

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on February 14, 2024, 4:57 pm based on SEC 13F filings Last update: February 14, 2024, 4:57 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Tang Capital Management Kevin C. Tang	3,667,600	$1,969,501	-9%	0.18%
2.	Millennium Management Israel Englander	2,990,279	$1,605,780	-2%	0%
3.	Biotechnology Value Fund / BVF Inc Mark Lampert	2,312,200	$1,241,651		0.03%
4.	OrbiMed Advisors Samuel Isaly	1,500,000	$805,500		0.01%
5.	Ikarian Capital Neil Shahrestani	1,171,939	$629,331		0.05%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Qiming	$16.00	312,500	Large Shareholder	2,370,142	2021-06-29	Filing
Aisling	$16.00	187,500	Large Shareholder	2,834,910	2021-06-29	Filing
Vertex	$16.00	250,000	Large Shareholder	2,307,642	2021-06-29	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Venbio	$4.12	702,737		1,905,430	2022-05-25	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Venbio Partners Llc	2,914,255	$1,564,955	0.23%
2.	Aisling Capital Management Lp	2,834,910	$1,522,347	0.45%
3.	Qiming U.s. Ventures Management, Llc	2,370,142	$1,272,766	1.16%
4.	Vanguard Group Inc	1,171,246	$628,959	0%
5.	Two Sigma Investments, Lp	364,892	$195,947	0%